Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03670225 · ClinicalTrials.gov registry record · NA
Evaluating Clinical Acceptance of a NPWT Wound Care System
A NA study of Diabetic Foot Ulcer and Pressure Ulcer, sponsored by Medela.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03670225 is a NA study of Diabetic Foot Ulcer and Pressure Ulcer that has completed, run by Medela. The registered enrollment target is 10 participants, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03670225, a NA study of Diabetic Foot Ulcer and Pressure Ulcer, has completed, sponsored by Medela.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.
Conditions Studied
Interventions
- DEVICE Invia Motion Endure
Study Locations (1)
Georgia
- Joseph M. Still Research Foundation - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2020-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03670225
The ClinicalTrials.gov registry entry for NCT03670225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (96% lower). The listed sponsor is Medela, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which Invia Motion Endure is the first listed.
NCT03670225 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT03670225 about?
NCT03670225 is a clinical study titled "Evaluating Clinical Acceptance of a NPWT Wound Care System". Determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.
What is the current status of trial NCT03670225?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-10-16. Estimated completion is 2020-01-30.
What conditions does trial NCT03670225 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Pressure Ulcer, Pressure Injury.
What interventions are being tested in trial NCT03670225?
The interventions under investigation include: Invia Motion Endure (DEVICE).
Who is sponsoring clinical trial NCT03670225?
This trial is sponsored by Medela, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03670225 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.